SCHEMBL8016617

SCHEMBL8016617

O=C(Nc1cccc2c(O)c(Cl)ccc12)C(Cl)(Cl)Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 8/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PARP14 Q460N5 1/20 0.38
▸ PDK1 Q15118 4/20 0.38
▸ PDK2 Q15119 4/20 0.38
▸ PDK3 Q15120 4/20 0.38
▸ PDK4 Q16654 4/20 0.38
▸ LMNA P02545 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20498063 0.83 TRPV1 (0.49) TRPV1ALDH1A1HPGDKDM4EGAA
SCHEMBL5351442 0.81 PARP14 (0.54) TRPV1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL8026174 0.81 TRPV1 (0.54) TRPV1ALDH1A1HPGDKDM4EGLA
SCHEMBL8029712 0.79 MEN1 (0.45) TRPV1ALDH1A1KDM4EGAASMN1; SMN2
SCHEMBL8017543 0.79 HPRT1 (0.50) TRPV1ALDH1A1HPGDSMN1; SMN2PARP14
SCHEMBL8033134 0.78 GABRP (0.44) TRPV1ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL8029142 0.77 TSHR (0.51) TRPV1ALDH1A1HPGDKDM4EGAA
SCHEMBL20498221 0.77 HSP90AA1 (0.47) TRPV1ALDH1A1HPGDPARP14LMNA
SCHEMBL2868307 0.70 MEN1 (0.66) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL18466732 0.68 PDK1 (0.48) ALDH1A1HPGDKDM4EGAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0603954-B1 Immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer JOHNSON & JOHNSON CLIN DIAG (US) 2000-03-08 — — EP disclosed
EP-0603953-B1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods JOHNSON & JOHNSON CLIN DIAG (US) 1999-02-17 — — EP disclosed
US-5736335-A Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents EASTMAN KODAK COMPANY (US) 1998-04-07 — — US disclosed
US-5641635-A Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents EASTMAN KODAK COMPANY (US) 1997-06-24 — — US disclosed
US-5372931-A Use of 4'-hydroxy- and 4'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods EASTMAN KODAK COMPANY (US) 1994-12-13 — — US disclosed
US-5372932-A Peroxidase-labeled immunoreactant; stabiliztion with a 4-hydroxy or 4-alkoxyarylacetamide EASTMAN KODAK COMPANY (US) 1994-12-13 — — US disclosed
EP-0603953-A1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 — — EP disclosed
EP-0603954-A2 Analytical element and immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 — — EP disclosed
Send feedback